Everyday life
Starting the Wegovy pill after 65: what the label says
The label gives one tablet schedule for adults and no separate one by age. It found no clinically significant difference in semaglutide levels by age, including 75 and older. The tablet trial included 21 people aged 65 or more, and the injection trials add two cautions for people 75 and older.
The Oolite team, from the FDA labels
Sources checked Oct 27, 2026
Published Nov 12, 2026
Updated Oct 27, 2026 · 2 min read
The short answer
The label gives one tablet schedule for adults and no separate one by age. It found no clinically significant difference in semaglutide levels by age, including 75 and older. The tablet trial included 21 people aged 65 or more, and the injection trials add two cautions for people 75 and older.
What the label says
The geriatric section (§8.5) starts with the people the trials enrolled. For the tablet, the number is small:
From the labelIn a WEGOVY® 25 mg tablets clinical trial for weight reduction and long-term maintenance, 16 (8%) WEGOVY® tablets-treated patients were aged 65 to less than 75 years and 5 (2%) WEGOVY® tablet-treated patients were aged 75 years and older
The tablet trial's participants had a mean age of 48. Most of what the label says about older adults comes from the injection trials, and above all from the cardiovascular outcomes trial, where 30 percent of the people on the shot were 65 to 75. From that trial:
From the labelNo overall difference in the effectiveness was observed between patients aged 65 years and older and younger adult patients.
Then two findings for people aged 75 and older:
From the labelIn the CV outcomes trial, patients aged 75 years and older reported more hip and pelvis fractures in the WEGOVY® injection-treated patients than placebo-treated patients.
From the labelPatients aged 75 years and older (WEGOVY® injection-treated and placebo-treated) reported more serious adverse reactions overall compared to younger adult patients
The second sentence counts both groups, on the drug and on placebo: it describes being older in a long trial, not only the medicine.
What age does not change
The pharmacology section (§12.3) measured how semaglutide moves through the body in different groups:
From the labelNo clinically significant differences in semaglutide pharmacokinetics were observed based on age (<65 years, 65 to 74, ≥75 years old), …
That is why the tablet dosing section has one schedule for every adult: 1.5 mg for the first 30 days, then 4 mg, then 9 mg, then 25 mg. The steps are the same at 45 and at 70. The pace beyond that, and whether to hold a step, are the prescriber's call, as they are at any age.
What to bring to the first appointment
After 65, the morning often already holds other tablets, and the Wegovy pill wants an empty stomach and its own 30 minutes. The list of everything you take, a history of falls, and how your stomach handles the first weeks are the useful things to put on the table.
Oolite's journal keeps how each day felt and any side effects with their date, and the report for your prescriber puts them in one page.
Questions people ask
Is there an upper age limit for the Wegovy pill?
The label does not name one. The tablet dosing section gives a single schedule for adults, from 1.5 mg to 25 mg, and the geriatric section reports people aged 75 and older in the trials rather than excluding them.
How many people over 65 took the tablet in its trial?
Sixteen people aged 65 to less than 75, which the label counts as 8 percent of the people on the tablets, and five aged 75 and older, 2 percent. Most of what the label knows about older adults comes from the larger injection trials.
Does age change how much semaglutide stays in the blood?
The label says no clinically significant differences in semaglutide pharmacokinetics were observed based on age, in three groups: under 65, 65 to 74, and 75 and older.
What does the label flag after 75?
In the injection cardiovascular trial, people aged 75 and older reported more hip and pelvis fractures on Wegovy than on placebo, and more serious adverse reactions overall than younger adults. The label reports these findings without a cause. Falls or fragile bones are worth raising with the prescriber at the start.
Sources
- Wegovy prescribing information, Novo Nordisk, §2.3, §6.1, §8.5 and §12.3, revised 06/2026 · Tablet trial: 16 (8%) aged 65 to less than 75 and 5 (2%) aged 75 and older, mean age 48; injection CV trial: no overall difference in effectiveness at 65 and older, more hip and pelvis fractures on Wegovy at 75 and older, more serious adverse reactions overall at 75 and older; no clinically significant differences in semaglutide pharmacokinetics by age (<65, 65 to 74, ≥75).
Sources checked Oct 27, 2026. This page is information, not medical advice: read the medical disclaimer, and talk to your prescriber or pharmacist about your own treatment.
Written by
The Oolite team, from the FDA labels
We make Oolite. Every answer starts from the FDA prescribing information, quoted word for word, and is rewritten when a label changes.
How these pages are madeOolite
The GLP-1 tracker for the pill and the shot.
The 30 minute timer, your shot day, the level chart and the dose reminder, on iPhone, with Apple Watch to log. Free to download, then a 14-day free trial.
